Celularity, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2017-09-01
- Employees
- 225
- Market Cap
- $66.1M
- Website
- http://www.celularity.com
Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With and Without Peripheral Arterial Disease
- Conditions
- Interventions
- First Posted Date
- 2014-10-15
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Celularity Incorporated
- Target Recruit Count
- 159
- Registration Number
- NCT02264288
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸University of Pennsylvania Health Systems, Philadelphia, Pennsylvania, United States
🇺🇸Premier Vein and Vascular Center, Houston, Texas, United States
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
- Conditions
- Interventions
- First Posted Date
- 2013-05-21
- Last Posted Date
- 2018-03-01
- Lead Sponsor
- Celularity Incorporated
- Target Recruit Count
- 15
- Registration Number
- NCT01859117
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States
🇺🇸Stanford University School of Medicine, Stanford, California, United States
A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease
- Conditions
- Interventions
- First Posted Date
- 2013-01-17
- Last Posted Date
- 2018-03-01
- Lead Sponsor
- Celularity Incorporated
- Target Recruit Count
- 14
- Registration Number
- NCT01769755
- Locations
- 🇺🇸
McGuire Veterans Affairs Medical Center, Richmond, Virginia, United States
🇺🇸Cedars Sinai Medical Center, Inflammatory Bowel Disease Center, Los Angeles, California, United States
🇺🇸University of Miami School of Medicine, Miami, Florida, United States
Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary Sarcoidosis
- Conditions
- Interventions
- First Posted Date
- 2011-09-26
- Last Posted Date
- 2018-03-01
- Lead Sponsor
- Celularity Incorporated
- Target Recruit Count
- 4
- Registration Number
- NCT01440192
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
🇺🇸University of Alabama, Birmingham - Division of Pulmonary, Allergy, and Critical Care Medicine, Birmingham, Alabama, United States
🇺🇸University of Cincinatti Medical Center, Cincinnati, Ohio, United States
Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke
- Conditions
- Interventions
- First Posted Date
- 2011-03-08
- Last Posted Date
- 2018-03-01
- Lead Sponsor
- Celularity Incorporated
- Target Recruit Count
- 44
- Registration Number
- NCT01310114
- Locations
- 🇺🇸
Chattanooga Center for Neurologic Research, Chattanooga, Tennessee, United States
Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2010-12-16
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Celularity Incorporated
- Target Recruit Count
- 26
- Registration Number
- NCT01261403
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸Desert Medical Advances, Palm Desert, California, United States
🇺🇸Advanced Pain Research Institute, Arcadia, California, United States
A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease
- Conditions
- Interventions
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Celularity Incorporated
- Target Recruit Count
- 50
- Registration Number
- NCT01155362
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
🇺🇸Case Western Reserve University, Cleveland, Ohio, United States
🇺🇸Yale School of Medicine Digestive Diseases, New Haven, Connecticut, United States